Cargando…
Intermedin protects against myocardial ischemia-reperfusion injury in diabetic rats
BACKGROUND: Diabetic patients, through incompletely understood mechanisms, endure exacerbated ischemic heart injury compared to non-diabetic patients. Intermedin (IMD) is a novel calcitonin gene-related peptide (CGRP) superfamily member with established cardiovascular protective effects. However, wh...
Autores principales: | Li, Hong, Bian, Yunfei, Zhang, Nana, Guo, Jia, Wang, Cheng, Lau, Wayne Bond, Xiao, Chuanshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703263/ https://www.ncbi.nlm.nih.gov/pubmed/23777472 http://dx.doi.org/10.1186/1475-2840-12-91 |
Ejemplares similares
-
Intermedin protects against renal ischemia-reperfusion injury by inhibiting endoplasmic reticulum stress
por: Wang, Yanhong, et al.
Publicado: (2015) -
Intermedin Alleviates Renal Ischemia-Reperfusion Injury and Enhances Neovascularization in Wistar Rats
por: Wang, Yanhong, et al.
Publicado: (2020) -
Protective effect of celastrol on myocardial ischemia–reperfusion injury
por: Li, Xiaoyan, et al.
Publicado: (2017) -
Intermedin protects HUVECs from ischemia reperfusion injury via Wnt/β-catenin signaling pathway
por: Wang, Yanhong, et al.
Publicado: (2019) -
SIRT1 protects against myocardial ischemia–reperfusion injury via activating eNOS in diabetic rats
por: Ding, Mingge, et al.
Publicado: (2015)